Core Viewpoint - Investors in the Medical - Drugs sector should consider Merck KGaA (MKKGY) as a better value opportunity compared to Madrigal (MDGL) based on various financial metrics and rankings [1]. Valuation Metrics - Merck KGaA has a Zacks Rank of 2 (Buy), indicating a stronger earnings outlook compared to Madrigal, which has a Zacks Rank of 4 (Sell) [3]. - MKKGY has a forward P/E ratio of 15.48, significantly lower than MDGL's forward P/E of 294.77, suggesting MKKGY is more reasonably priced [5]. - The PEG ratio for MKKGY is 6.05, while MDGL's PEG ratio is 6.80, indicating MKKGY may offer better value relative to its expected earnings growth [5]. - MKKGY's P/B ratio is 0.57, contrasting sharply with MDGL's P/B of 17.38, further supporting the notion that MKKGY is undervalued [6]. - Based on these metrics, MKKGY holds a Value grade of A, while MDGL has a Value grade of F, reinforcing MKKGY's position as the more attractive investment [6].

Core Viewpoint - Nu Skin Enterprises, Inc. (NUS) is expected to report declines in both revenue and earnings for the fourth quarter of 2025, with revenue estimates at $382.7 million, reflecting a 14.1% decrease year-over-year [1]. Revenue Expectations - The Zacks Consensus Estimate for quarterly revenues is set at $382.7 million, indicating a 14.1% decline from the previous year's quarter [1]. - Management has guided fourth-quarter revenues between $365 million and $400 million, suggesting a year-over-year decline of 10-18% [4]. - Excluding the contribution from the divested Mavely business, revenues are projected to fall by 12-3% [4]. Earnings Projections - The consensus estimate for quarterly earnings remains unchanged at 30 cents per share, which represents a 21.1% decline from the same quarter last year [2]. - Nu Skin anticipates fourth-quarter earnings per share to be between 25 and 35 cents, down from adjusted earnings of 38 cents reported in the previous year [6]. Market Conditions - The company is facing a challenging macroeconomic environment affecting discretionary spending in beauty and wellness [3]. - There has been a decline in customers, paid affiliates, and sales leaders, indicating ongoing pressures in several markets [3]. - Increased competition in the social commerce beauty space, particularly in North America, is also impacting performance [4]. Geographic Performance - Latin America has shown strong performance, with revenues increasing by 53% year-over-year in the third quarter [5]. - Sequential growth was reported in Europe & Africa, Southeast Asia Pacific, South Korea, and Hong Kong & Taiwan, with improving trends noted in Mainland China [5]. Strategic Initiatives - The limited sales leader preview of Prysm iO and the start of pre-market activities in India are expected to influence fourth-quarter performance positively [5]. - Despite the anticipated decline in sales, Nu Skin has achieved five consecutive quarters of adjusted gross margin expansion, supported by product mix improvements and cost discipline [6].

Market Overview - The broader equity markets experienced a recovery after a significant sell-off, particularly driven by technology stocks like NVIDIA and Broadcom [1] - Bitcoin rebounded after dropping to $60,062.00, indicating a shift in investor sentiment towards risk-off strategies [1][2] Financial Sector Insights - The finance sector faces latent threats from AI and disappointing retail sales data, contributing to market volatility [2] - Investors are adopting a "wait-and-see" approach, focusing on "cash cow" stocks that offer higher returns [2] Key Financial Metrics - Return on Equity (ROE) is highlighted as a crucial metric for assessing a company's profitability and financial health [3][4] - A high ROE indicates effective reinvestment of cash at high rates of return, distinguishing profit-generating companies from less efficient ones [3][4] Stock Screening Criteria - Stocks are screened based on parameters such as Cash Flow greater than $1 billion and ROE exceeding industry averages [5] - Additional criteria include Price/Cash Flow lower than industry averages and Return on Assets (ROA) greater than industry benchmarks [6] Selected Stocks - Alcoa Corporation (AA): Engaged in mining and electricity generation, with a trailing four-quarter earnings surprise of 44.5% and a Zacks Rank 1 [7][8] - Globe Life Inc. (GL): An insurance holding company with a Zacks Rank 2 and a focus on life and supplemental health insurance [9][10] - Banco Bilbao Vizcaya Argentaria, S.A. (BBVA): Provides banking and asset management services, with a long-term earnings growth expectation of 12% and a Zacks Rank 1 [10][11] - The TJX Companies, Inc. (TJX): A leading off-price retailer with a long-term earnings growth expectation of 10.2% and a Zacks Rank 2 [12][13] - TE Connectivity plc (TEL): A global technology company focused on connectivity solutions, with a long-term earnings growth expectation of 12% and a Zacks Rank 1 [14][15]

Core Insights - USA Compression Partners (USAC) is expected to report fourth-quarter results on February 17, with earnings estimated at 28 cents per share and revenues at $251.58 million [1][8] Group 1: Previous Quarter Performance - In the last reported quarter, USAC's earnings were 26 cents per common unit, exceeding the Zacks Consensus Estimate of 22 cents, while revenues reached $250.3 million, surpassing the estimate of $247 million [2] - USAC has a mixed earnings surprise history, beating estimates in two of the last four quarters and missing in the other two, resulting in an average negative surprise of 6.5% [2] Group 2: Fourth Quarter Expectations - The Zacks Consensus Estimate for fourth-quarter earnings indicates a 55.56% year-over-year increase, while revenues are projected to rise by 2.31% compared to the previous year [3] - Revenue growth is anticipated due to strong performance in contract operations, with a projected 5.2% increase from the year-ago quarter, and average revenue per horsepower expected to rise by 5.1% [5][8] Group 3: Cost Considerations - USAC's total operations costs for the fourth quarter are projected to be $79.9 million, reflecting a 2.3% increase from the previous year, influenced by ongoing inflationary pressures [6][8] Group 4: Earnings Prediction Model - The Zacks model does not predict a definitive earnings beat for USAC this quarter, as the Earnings ESP is -7.14%, despite the company holding a Zacks Rank of 2 (Buy) [7][9]

The market expects OPENLANE (OPLN) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released ...

Company Overview - Amgen is one of the largest biotech companies globally, focusing on oncology, cardiovascular disease, inflammation, bone health, and rare diseases [11] - The company has developed significant drugs such as Epogen and Neupogen, and launched next-generation products like Aranesp and Neulasta [11] - Amgen's acquisition of Immunex Corporation provided access to the blockbuster drug Enbrel, although older drugs are facing declining sales due to competition [11] Current Stock Performance - Amgen is currently rated 3 (Hold) on the Zacks Rank, with a VGM Score of B [12] - The stock has a Momentum Style Score of B, with shares increasing by 12.4% over the past four weeks [12] - For fiscal 2026, eight analysts have revised their earnings estimates upwards, increasing the Zacks Consensus Estimate by $0.48 to $22.19 per share [12] Investment Considerations - With a solid Zacks Rank and strong Momentum and VGM Style Scores, Amgen is recommended for investors' consideration [13]

Core Insights - Zacks Premium offers tools for investors to enhance their stock market strategies, including daily updates, research reports, and stock screens to improve investment confidence [1] Zacks Style Scores - Zacks Style Scores are indicators that help investors select stocks likely to outperform the market in the next 30 days, rated from A to F based on value, growth, and momentum characteristics [2] - The Value Score identifies attractive stocks using ratios like P/E and Price/Sales, focusing on stocks that are undervalued [3] - The Growth Score evaluates a company's future prospects through earnings, sales, and cash flow to find stocks with sustainable growth [4] - The Momentum Score leverages trends in stock prices and earnings estimates to identify favorable times for investment [5] - The VGM Score combines the three Style Scores to highlight stocks with the best value, growth, and momentum characteristics [6] Zacks Rank - The Zacks Rank is a proprietary model that uses earnings estimate revisions to assist investors in building successful portfolios [7] - Stocks rated 1 (Strong Buy) have historically produced an average annual return of +23.83% since 1988, significantly outperforming the S&P 500 [8] - Investors can choose from over 800 top-rated stocks, and the Style Scores help narrow down selections [9] Investment Strategy - For optimal returns, investors should focus on stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B [10] - Stocks with lower ranks (3, 4, 5) should still have strong Style Scores to maximize upside potential [11] Company Spotlight: CyberArk - CyberArk Software Ltd. is a key player in IT security, serving over 5,400 global businesses, including more than 50% of Fortune 500 companies [12] - CyberArk holds a Zacks Rank of 2 (Buy) and a VGM Score of B, making it a strong candidate for growth investors [12] - The company forecasts a year-over-year earnings growth of 10.9% for the current fiscal year, with upward revisions in earnings estimates [13] - CyberArk has an average earnings surprise of +20.9%, indicating strong performance potential [13]

Core Insights - Zacks Premium offers various tools for investors to enhance their stock market strategies and confidence [1] - The Zacks Style Scores are designed to complement the Zacks Rank, helping investors identify stocks likely to outperform the market in the short term [2] Zacks Style Scores Overview - Stocks are rated from A to F based on value, growth, and momentum, with higher scores indicating a better chance of outperforming the market [3] - The Style Scores are categorized into four types: Value Score, Growth Score, Momentum Score, and VGM Score [3][4][5][6] Value Score - Focuses on identifying undervalued stocks using financial ratios such as P/E, PEG, and Price/Sales to find attractive investment opportunities [3] Growth Score - Concentrates on a company's financial health and future growth potential, analyzing projected and historical earnings, sales, and cash flow [4] Momentum Score - Targets stocks with upward or downward price trends, utilizing recent price changes and earnings estimate adjustments to identify favorable buying opportunities [5] VGM Score - Combines all three Style Scores to provide a comprehensive rating, helping investors find stocks with the best value, growth prospects, and momentum [6] Zacks Rank Integration - The Zacks Rank uses earnings estimate revisions to guide investors, with 1 (Strong Buy) stocks historically yielding an average annual return of +23.83% since 1988, significantly outperforming the S&P 500 [7] - A large number of stocks are rated, with over 800 top-rated options available, making it essential to use Style Scores for effective selection [8] Investment Strategy - To maximize returns, investors should focus on stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B, ensuring high potential for upside [9] - Stocks rated 4 (Sell) or 5 (Strong Sell) should be avoided, even if they have high Style Scores, due to declining earnings forecasts [10] Company Spotlight: ATI Inc. - ATI Inc., based in Pittsburgh, PA, is a diversified specialty materials producer and currently holds a 1 (Strong Buy) rating on the Zacks Rank with a VGM Score of B [11] - The company is particularly appealing to growth investors, with a Growth Style Score of A and a projected year-over-year earnings growth of 27.2% for the current fiscal year [12] - Recent earnings estimates for fiscal 2026 have been revised upward, with the Zacks Consensus Estimate increasing by $0.17 to $4.12 per share, alongside an average earnings surprise of +11.2% [12]

Core Insights - Zacks Premium provides various tools for investors to enhance their stock market engagement and confidence, including daily updates, research reports, and stock screens [1][2] Zacks Style Scores - The Zacks Style Scores are indicators that rate stocks based on value, growth, and momentum methodologies, helping investors identify stocks likely to outperform the market in the short term [3] - Stocks are rated from A to F, with A indicating the highest potential for outperformance [4] Value Score - The Value Style Score identifies attractive and discounted stocks using ratios like P/E, PEG, and Price/Sales [4] Growth Score - The Growth Style Score focuses on a company's financial health and future outlook, analyzing projected and historical earnings, sales, and cash flow [5] Momentum Score - The Momentum Style Score helps investors capitalize on price trends by analyzing short-term price changes and earnings estimate revisions [6] VGM Score - The VGM Score combines all three Style Scores, providing a comprehensive rating based on value, growth, and momentum [7] Zacks Rank - The Zacks Rank is a proprietary model that uses earnings estimate revisions to guide investors, with 1 (Strong Buy) stocks historically yielding an average annual return of +23.83% since 1988, outperforming the S&P 500 [8] - There are typically over 800 top-rated stocks available, making it essential to utilize Style Scores for better stock selection [9] Stock Recommendation: Texas Instruments (TXN) - Texas Instruments is rated 3 (Hold) with a VGM Score of B, and it is highlighted as a potential growth investment with a Growth Style Score of B, forecasting a 17.4% year-over-year earnings growth for the current fiscal year [12] - Nine analysts have raised their earnings estimates for fiscal 2026, with the Zacks Consensus Estimate increasing by $0.35 to $6.40 per share, and TXN has an average earnings surprise of +6.5% [13]

Company Performance - James Hardie (JHX) has returned approximately 17.5% since the beginning of the calendar year, outperforming the average return of 16.6% for the Construction sector [4] - The Zacks Consensus Estimate for JHX's full-year earnings has increased by 11.4% over the past three months, indicating a stronger analyst sentiment and improving earnings outlook [3] Industry Comparison - James Hardie belongs to the Building Products - Miscellaneous industry, which includes 34 stocks and currently ranks 171 in the Zacks Industry Rank, with an average gain of 12% this year, showing that JHX is performing better than its industry [5] - In contrast, MasTec (MTZ), another outperforming stock in the Construction sector, is part of the Building Products - Heavy Construction industry, which has seen a 24.1% increase since the start of the year and ranks 87 [6]